PARP1 and neurodegenerative disease: In the last decade, a growing body of experimental evidence suggests that PARP-1 is activated in neurodegenerative diseases, neurodevelopmental disorders and aging, leading to neuroinflammation, autophagy dysregulation and mitochondrial dysfunction [105,106,107,108].